Loading data for GDRX — first visit, this takes a few seconds.

GoodRx Holdings, Inc. (GDRX)

NasdaqGS: GDRX · 실시간 가격 · USD

3.46

-0.03 (-0.86%)

종가 기준: Sep 02, 2026, 4:11 PM

알림

Alert

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

데이터 없음

매수호가	2.54
시가총액	1.21B
매출 (ttm)	785M
순이익 (ttm)	16.2M
	1.58
	0.06
	59.08
	9.95
P/B (ttm)	1.86
P/S (ttm)	1.54
실적 발표일	Nov 3, 2026

매도호가	4.44
거래량	1,588,157
평균 거래량 (20일)	1,408,190
시가	3.46
전일 종가	3.49
일중 범위	3.45 - 3.58
52주 범위	1.77 - 5.81
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

GDRX 소개

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and p...

[더 보기]

산업 Health Information Services

섹터 Healthcare

IPO 일자 Sep 23, 2020

직원 수 697

상장 거래소 NasdaqGS

티커 GDRX

웹사이트 https://www.goodrx.com

전체 기업 정보

재무 실적

2025년 GoodRx s의 매출은 796.85M로, 전년 792.32M 대비 0.57% 증가했습니다. 순이익은 30.44M로, 85.72% 증가했습니다.

재무제표

어닝 서프라이즈

GoodRx s가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $200.41M 예상치 하회 $0, 및 -1.31% 전년 대비 감소.
EPS 0.08 예상치 하회 0.00, 및 -11.11% 전년 대비 감소.

다음 실적 발표

GoodRx Holdings, Inc.의 실적 발표 예정일은 Nov 3, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

주가가 움직인 이유

뉴스

3일 전 · StockStory

1 Momentum Stock with Exciting Potential and 2 That Underwhelm

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developm...

3주 전 · StockStory

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at GoodRx (NASDAQ:GDRX) and its peers.

3주 전 · StockStory

1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside ri...

3주 전 · Simply Wall St.

GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook

GoodRx Holdings has delivered a steep 89.7% share price decline over the past five years. The stock has recently bounced, which sits awkwardly with valuation checks that currently lean toward the shar...

3주 전 · Simply Wall St.

GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise

GoodRx Holdings (GDRX) is back in focus after its Q2 2026 earnings report on 5 August, along with raised full-year revenue guidance and a leadership change that appoints Justin Fengler as Chief Financ...

2 페이지 중 1

GoodRx Holdings, Inc. (GDRX)